These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 356208

  • 1. Steroid diabetes after renal transplantation--a preliminary report.
    Gunnarsson R, Arner P, Lundgren G, Magnusson G, Ostman J, Groth CG.
    Scand J Urol Nephrol Suppl; 1977; (42):191-4. PubMed ID: 356208
    [Abstract] [Full Text] [Related]

  • 2. Relative risk of new-onset diabetes during the first year after renal transplantation in patients receiving tacrolimus or cyclosporine immunosuppression.
    Hoitsma AJ, Hilbrands LB.
    Clin Transplant; 2006; 20(5):659-64. PubMed ID: 16968494
    [Abstract] [Full Text] [Related]

  • 3. Post transplant diabetes mellitus in live related renal allograft recipients: a single centre experience.
    Saxena S, Dash SC, Guleria S, Mittal R, Agarwal SK, Tiwari SC, Mehta SN.
    J Assoc Physicians India; 1996 Jul; 44(7):472, 477-9. PubMed ID: 9282609
    [Abstract] [Full Text] [Related]

  • 4. Steroid diabetes--a sign of overtreatment with steroids in the renal graft recipient?
    Gunnarsson R, Lundgren G, Magnusson G, Ost L, Groth CG.
    Scand J Urol Nephrol Suppl; 1980 Jul; 54():135-8. PubMed ID: 7013032
    [Abstract] [Full Text] [Related]

  • 5. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
    Lerut JP, Ciccarelli O, Mauel E, Gheerardhyn R, Talpe S, Sempoux C, Laterre PF, Roggen FM, Van Leeuw V, Otte JB, Gianello P.
    Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040
    [Abstract] [Full Text] [Related]

  • 6. Steroid avoidance immunosuppression in low-risk kidney transplant recipients.
    Heilman RL, Mazur MJ, Reddy KS, Moss A, Post D, Mulligan D.
    Transplant Proc; 2005 May; 37(4):1785-8. PubMed ID: 15919466
    [Abstract] [Full Text] [Related]

  • 7. Steroid withdrawal in kidney transplant recipients: is it a safe option?
    Sanfey H, Haussman G, Isaacs I, Ishitani M, Lobo P, McCullough C, Pruett T.
    Clin Transplant; 1997 Oct; 11(5 Pt 2):500-4. PubMed ID: 9361950
    [Abstract] [Full Text] [Related]

  • 8. Clinicoepidemiologic study of posttransplant diabetes after living-donor renal transplant.
    Elmagd MM, Bakr MA, Metwally AH, Wahab AM.
    Exp Clin Transplant; 2008 Mar; 6(1):42-7. PubMed ID: 18405244
    [Abstract] [Full Text] [Related]

  • 9. Posttransplant diabetes mellitus in renal allograft recipients: A prospective multicenter study at 2 years.
    Marcén R, Morales JM, del Castillo D, Campistol JM, Serón D, Valdés F, Anaya F, Andrés A, Arias M, Bustamante J, Capdevila L, Escuin F, Gil-Vernet S, Gonzalez-Molina M, Lampreave I, Oppenheimer F, Pallardó L, Spanish Renal Forum.
    Transplant Proc; 2006 Dec; 38(10):3530-2. PubMed ID: 17175323
    [Abstract] [Full Text] [Related]

  • 10. Hypertension in renal transplant recipients on cyclosporin A and corticosteroids and azathioprine.
    Hamilton DV, Carmichael DJ, Evans DB, Calne RY.
    Transplant Proc; 1982 Sep; 14(3):597-600. PubMed ID: 6758243
    [No Abstract] [Full Text] [Related]

  • 11. Posttransplant diabetes mellitus in cyclosporine-treated renal allograft patients: a case-control study.
    Copstein LA, Zelmanovitz T, Gonçalves LF, Manfro RC.
    Transplant Proc; 2004 May; 36(4):882-3. PubMed ID: 15194302
    [Abstract] [Full Text] [Related]

  • 12. Steroid-related complications in the cyclosporine era.
    Fryer JP, Granger DK, Leventhal JR, Gillingham K, Najarian JS, Matas AJ.
    Clin Transplant; 1994 Jun; 8(3 Pt 1):224-9. PubMed ID: 8061360
    [Abstract] [Full Text] [Related]

  • 13. Determinants of long-term allograft function following steroid withdrawal in renal transplant recipients.
    Hricik DE, Seliga RM, Fleming-Brooks S, Bartucci MR, Schulak JA.
    Clin Transplant; 1995 Oct; 9(5):419-23. PubMed ID: 8541637
    [Abstract] [Full Text] [Related]

  • 14. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months.
    Aichberger C, Eberl T, Riedmann B, Pernthaler H, Ofner D, Königsrainer A, Margreiter R.
    Clin Transplant; 1996 Apr; 10(2):209-12. PubMed ID: 8664521
    [Abstract] [Full Text] [Related]

  • 15. Late medical complications of renal transplantation.
    Ginn HE.
    Arch Intern Med; 1969 May; 123(5):537-42. PubMed ID: 4888972
    [No Abstract] [Full Text] [Related]

  • 16. Independent predictors of renal dysfunction after heart transplantation in patients with normal pretransplant renal function.
    Garrido IP, Crespo-Leiro MG, Paniagua MJ, Muñiz J, Vázquez-Rey E, Pérez-Fernández R, García-Lara J, Cuenca-Castillo JJ, Castro-Beiras A.
    J Heart Lung Transplant; 2005 Sep; 24(9):1226-30. PubMed ID: 16143237
    [Abstract] [Full Text] [Related]

  • 17. [Diabetes induced by corticoids in 6 children after renal transplantation].
    Bakchine H, Niaudet P, Gagnadoux MF, Broyer M, Czernichow P.
    Arch Fr Pediatr; 1984 Apr; 41(4):261-4. PubMed ID: 6383252
    [Abstract] [Full Text] [Related]

  • 18. Ocular complications in renal transplant recipients.
    Pavlin CR, deVeber GA, Cook GT, Chisholm LD.
    Can Med Assoc J; 1977 Aug 20; 117(4):360-2. PubMed ID: 329970
    [Abstract] [Full Text] [Related]

  • 19. A long-term study on hyperlipidemia in stable renal transplant recipients.
    Tse KC, Lam MF, Yip PS, Li FK, Lai KN, Chan TM.
    Clin Transplant; 2004 Jun 20; 18(3):274-80. PubMed ID: 15142048
    [Abstract] [Full Text] [Related]

  • 20. New-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression.
    Wagner K, Webber SA, Kurland G, Boyle GJ, Miller SA, Cipriani L, Griffith BP, Fricker FJ.
    J Heart Lung Transplant; 1997 Mar 20; 16(3):275-82. PubMed ID: 9087870
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.